ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $537,000 | -5.0% | 1,417 | -21.0% | 0.04% | +8.3% |
| Q1 2022 | $565,000 | -26.6% | 1,793 | -18.4% | 0.04% | -28.0% |
| Q4 2021 | $770,000 | +13.7% | 2,198 | -2.0% | 0.05% | +4.2% |
| Q3 2021 | $677,000 | -2.3% | 2,243 | -2.6% | 0.05% | -5.9% |
| Q2 2021 | $693,000 | +0.3% | 2,303 | -8.2% | 0.05% | -7.3% |
| Q1 2021 | $691,000 | -7.4% | 2,510 | -1.1% | 0.06% | -16.7% |
| Q4 2020 | $746,000 | +8.4% | 2,537 | -3.2% | 0.07% | -8.3% |
| Q3 2020 | $688,000 | -5.0% | 2,621 | -18.5% | 0.07% | -11.1% |
| Q2 2020 | $724,000 | +121.4% | 3,216 | +29.5% | 0.08% | +80.0% |
| Q1 2020 | $327,000 | – | 2,483 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |